insights_auto
Outlook: 56.0% bullish·12.0% bearish
Go to analysischevron_right
NKTR:NASDAQ
Nektar Therapeutics
$40.26
arrow_upward
+0.88%(+0.35) 1D
$40.26
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 11 analysts giving stock ratings to NKTR in the past 3 months
Strong buy
Buy
9
Hold
2
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for NKTR in the last 3 months.
Highest
Current $40.26
$192.00 (+376.90%)
Average
$141.56 (+251.61%)
Lowest
$50.00 (+24.19%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Samantha Semenkow Citi | Buy | Reiterated | $151.00 | +275.1% | 10/05/2026 |
Unknown Analyst B. Riley Securities | Buy | Maintained | $150.00 | +272.6% | 10/02/2026 |
Roger Song Jefferies | Buy | Maintained | $150.00 | +272.6% | 10/01/2026 |
Andy Hsieh William Blair | Buy | Maintained | - | - | 10/01/2026 |
Arthur He CFA H.C. Wainwright | Buy | Maintained | $185.00 | +359.5% | 10/02/2026 |
Julian Harrison BTIG | Buy | Maintained | $178.00 | +342.1% | 09/29/2026 |
Edward Nash Canaccord Genuity | Buy | Maintained | $153.00 | +280% | 09/28/2026 |
Martin Fan Wedbush | Hold | Reiterated | $50.00 | +24.2% | 09/23/2026 |
Jessica Fye J.P. Morgan | Hold | Initiated | $65.00 | +61.5% | 08/21/2026 |
Yasmeen Rahimi Piper Sandler | Buy | Maintained | $192.00 | +376.9% | 08/20/2026 |
Marc Frahm TD Cowen | Buy | Maintained | - | - | 08/13/2026 |
Jay Olson Oppenheimer | Buy | Maintained | $140.00 | +247.7% | 05/08/2026 |
Mayank Mamtani B. Riley Securities | Buy | Maintained | $150.00 | +272.6% | 02/23/2026 |